GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders

GENFIT completes a royalty financing of up to €185 million with HCRx after unanimous OCEANE bondholder approval, triggering a €130 million upfront payment with potential for an additional €55 million upon achieving near-term milestonesNon-dilutive financing extends cash runway beyond 2027 and supports GENFIT’s R&D effortsFinancing strengthens GENFIT's ACLF pipeline development and commitment to transformative therapiesGENFIT to use €61.66 million to repurchase 1,882,891 2025 OCEANEs after exercise by certai ...